Medicare Enrolled

Dr. Carol Deline, M.D.

Neurology with Special Qualifications in Child Neurology Physician · Corpus Christi, TX
Low-engagement
3533 S ALAMEDA ST, Corpus Christi, TX 78411
3616946747
In practice since 2006 (20 years)
NPI: 1760441158 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Deline from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deline? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Deline

Dr. Carol Deline is a neurology with special qualifications in child neurology physician in Corpus Christi, TX, with 20 years in practice.

Between the years covered by Open Payments, Dr. Deline received a total of $4,528 from 33 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology with special qualifications in child neurology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Deline is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $4,528 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,528
Total received (2018-2024)
Avg $647/year across 7 years
Top 28% in TX for neurology with special qualifications in child neurology physician
33
Companies
102
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,076 (90.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$452 (10.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$498
2023
$711
2022
$860
2021
$842
2020
$77
2019
$665
2018
$874

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$901
LivaNova USA, Inc.
$671
Supernus Pharmaceuticals, Inc.
$436
GENZYME CORPORATION
$329
PTC Therapeutics, Inc.
$204
GlaxoSmithKline, LLC.
$185
bioMerieux Inc
$121
Travere Therapeutics, Inc.
$120
Merck Sharp & Dohme Corporation
$116
Rhythm Pharmaceuticals, Inc.
$112
BioMarin Pharmaceutical Inc.
$106
Teva Pharmaceuticals USA, Inc.
$105
Pharming Healthcare, Inc.
$103
Ultragenyx Pharmaceutical Inc.
$100
ACADIA Pharmaceuticals Inc
$96
UCB, Inc.
$83
Marinus Pharmaceuticals, Inc.
$82
Neurelis, Inc.
$79
Sunovion Pharmaceuticals Inc.
$76
Phadia US Inc.
$74
JAZZ PHARMACEUTICALS INC.
$62
Sarepta Therapeutics, Inc.
$52
Sumitomo Pharma America, Inc.
$47
Zogenix Inc.
$35
ITF Therapeutics LLC
$31
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$29
AQUESTIVE THERAPEUTICS, INC.
$29
AveXis
$29
Greenwich Biosciences, Inc.
$25
Otter Pharmaceuticals, LLC
$25
SK Life Science, Inc.
$23
Lundbeck LLC
$21
Genentech USA, Inc.
$21
Top 3 companies account for 44.3% of total payments
Associated products mentioned in payments ›
AJOVY · APTIOM · BEXSERO · BIOFIRE SPOTFIRE Respiratory (R) Panel · Brineura · Briviact · Crysvita · DAYBUE · DISEASE STATE · EMFLAZA · EPIDIOLEX · Emflaza · Epidiolex · Evrysdi · Exondys 51 · FABRAZYME · Fintepla · GARDASIL · ImmunoCAP · JOENJA · ONFI · OXTELLAR XR · QELBREE · SPINRAZA · SYMPAZAN · Spinraza · TROKENDI XR · Thiola · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · Vimizim · ZOLGENSMA · ZTALMY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology with special qualifications in child neurology physician in Corpus Christi?
Compare neurology with special qualifications in child neurology physicians in the Corpus Christi area by procedure volume, costs, and industry payment transparency.
Browse neurology with special qualifications in child neurology physicians nearby

Geographic Context

Neurology with Special Qualifications in Child Neurology Physicians within 10 mi
1
Per 100K population
0.3
County median income
$66,021
Nearest hospital
CORPUS CHRISTI MEDICAL CENTER,THE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Deline is a neurology with special qualifications in child neurology physician, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Deline receive payments from pharmaceutical companies?
Yes. Dr. Deline received a total of $4,528 from 33 companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Deline) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →